We’re not just a healthcare company. We’re an organization committed to driving lasting change in health. Over 100 years ago, our Danish founders planted a seed that’s grown into our driving mission: to defeat serious chronic diseases.
Transforming possibilities from lab to factory, we deliver real progress that redefines what's next. This mindset is woven into our history, our culture and our approach. It reflects how we balance scientific excellence with a deep sense of humanity and how we remain ambitious yet always put people first.
Today, we treat over eleven million people in the U.S. with more than 20 medicines helping patients across four therapeutic areas.
Our unique structure isn't just a detail – it's our driving force. Backed by the Novo Nordisk Foundation, one of the world's largest philanthropies, we approach our responsibility with a fundamentally different outlook.
That means being guided by our bold ambition to achieve zero environmental impact across our entire value chain by 2045. To stay on track, we’ve set an interim goal of eliminating CO2 emissions from operations and transport by 2030 – relying on renewable energy sources like wind, water and solar in the U.S.
To us, accountability also means providing better access and affordable care. In keeping with that responsibility, our NovoCare Affordability Program has helped over 1 million US patients afford their medicines.
See where we stand on issues related to affordability and access.
The Novo Nordisk Way describes the values and behaviors that guide everything we do. It is rooted in the principles and vision of our founders who set out on an ambitious journey to drive change for patients with diabetes in 1923.
Today, we are thousands of colleagues applying the same passion, skills, and commitment to our purpose of driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
Our key values of openness, accountability, and respect underpin our work to reimagine a healthier world. To help us live these values, "Our 10 Essentials", guide the decisions and actions of every Novo Nordisk emplopyee.
1. Create value by having a patient-centered business approach.
2. Set ambitious goals and are empowered to achieve them.
3. Hold ourselves accountable for our financial, environmental, and social performance.
4. Remain curious and innovate for the benefit of patients and society at large.
5. Build and maintain good relations with our stakeholders.
6. Value inclusiveness and diversity and treat everyone with respect.
7. Focus on performance and personal development.
8. Foster a healthy and engaging working environment.
9. Strive for agility and simplicity in everything we do.
10. Choose to never compromise on quality and ethics.
As a life sciences employer focused on treating a diverse array of
patients, our employee populations must reflect the diversity of the
communities we serve. That's why we have a responsibility to make
Diversity, Equity, Inclusion & Belonging (DEI&B) part of
everything we do—from developing our products to building and
supporting our workforce.
Learn
how we bring this approach to life through our culture.
We believe it takes more than medicine to improve the lives of people living with serious chronic conditions. Our unordinary approach to care is grounded in advancing scientific breakthroughs, expanding access to life-saving medicines, and ensuring long-term health.
By coupling a deep disease understanding with empathy, we’re always innovating so we can provide more solutions in the future.
Learn how we are transforming care through science across our key therapeutic areas:
- Cardiovascular Disease
- Diabetes
- Obesity
- Rare Diseases
In 1923, our Danish cofounders began a journey to address the needs of those with diabetes by developing insulin. After 100 years, our mission has expanded, but our goal of improving the lives of patients has remained the same.
Read about our history of innovation and philanthrophy.
Our US headquarters plays a critical role in the vibrancy of the life sciences industry. Here we are responsible for sales, marketing and clinical trials management for all Novo Nordisk US products.
Our Cell Therapy R&D spans the full value chain of drug discovery, from early research to clinical development. This site is focused on innovation in stem cell-based replacement therapies.
Download our California location fact sheet.
Our manufacturing and research facility for RNAi therapeutics. This site specializes in operations and chemistry manufacturing and controls (CMC) for oligonucleotides and RNAi therapeutics.
This site expands our manufacturing capacity to meet current and future demand for our rare and chronic disease products. Operators and technicians work various shifts around-the-clock depending on facility and production needs.
Our greater Boston R&D hub, located in Lexington, Watertown and Cambridge, brings together the best minds in life science innovation. Here, we are building for the future, creating a distinct R&D community based on collaboration, partnerships, and cutting-edge research.
For more than 30 years, North Carolina has been home to Novo Nordisk’s first and largest manufacturing presence in the US. With a facility located in Durham, two additional sites in Clayton, and currently undergoing a $4.1 billion expansion, our teams operate continuously to produce diabetes and obesity medications serving millions of patients.
Our West Lebanon, New Hampshire site is a life-science production facility focused on continuous manufacturing to deliver products for rare bleeding disorders and growth disorders.
Our newly acquired manufacturing facility in Petersburg is focused on increasing development and production of future Novo Nordisk products.
